
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease
Courtney Lane‐Donovan, Joachim Herz
Trends in Endocrinology and Metabolism (2017) Vol. 28, Iss. 4, pp. 273-284
Open Access | Times Cited: 135
Courtney Lane‐Donovan, Joachim Herz
Trends in Endocrinology and Metabolism (2017) Vol. 28, Iss. 4, pp. 273-284
Open Access | Times Cited: 135
Showing 1-25 of 135 citing articles:
Liver X receptors in lipid signalling and membrane homeostasis
Bo Wang, Peter Tontonoz
Nature Reviews Endocrinology (2018) Vol. 14, Iss. 8, pp. 452-463
Open Access | Times Cited: 525
Bo Wang, Peter Tontonoz
Nature Reviews Endocrinology (2018) Vol. 14, Iss. 8, pp. 452-463
Open Access | Times Cited: 525
Microglia-Mediated Synapse Loss in Alzheimer's Disease
Lawrence Rajendran, Rosa Chiara Paolicelli
Journal of Neuroscience (2018) Vol. 38, Iss. 12, pp. 2911-2919
Open Access | Times Cited: 291
Lawrence Rajendran, Rosa Chiara Paolicelli
Journal of Neuroscience (2018) Vol. 38, Iss. 12, pp. 2911-2919
Open Access | Times Cited: 291
The integration of inflammaging in age-related diseases
Tamàs Fülöp, Jacek M. Witkowski, Fabiola Olivieri, et al.
Seminars in Immunology (2018) Vol. 40, pp. 17-35
Closed Access | Times Cited: 286
Tamàs Fülöp, Jacek M. Witkowski, Fabiola Olivieri, et al.
Seminars in Immunology (2018) Vol. 40, pp. 17-35
Closed Access | Times Cited: 286
Beyond the neuron–cellular interactions early in Alzheimer disease pathogenesis
Christopher M. Henstridge, Bradley T. Hyman, Tara L. Spires‐Jones
Nature reviews. Neuroscience (2019) Vol. 20, Iss. 2, pp. 94-108
Open Access | Times Cited: 281
Christopher M. Henstridge, Bradley T. Hyman, Tara L. Spires‐Jones
Nature reviews. Neuroscience (2019) Vol. 20, Iss. 2, pp. 94-108
Open Access | Times Cited: 281
Rab GTPases and Membrane Trafficking in Neurodegeneration
Ferdi Rıdvan Kiral, Friederike E. Kohrs, Eugene Jennifer Jin, et al.
Current Biology (2018) Vol. 28, Iss. 8, pp. R471-R486
Open Access | Times Cited: 201
Ferdi Rıdvan Kiral, Friederike E. Kohrs, Eugene Jennifer Jin, et al.
Current Biology (2018) Vol. 28, Iss. 8, pp. R471-R486
Open Access | Times Cited: 201
Noncoding RNAs in Alzheimer's disease
Maria Laura Idda, Rachel Munk, Kotb Abdelmohsen, et al.
Wiley Interdisciplinary Reviews - RNA (2018) Vol. 9, Iss. 2
Open Access | Times Cited: 196
Maria Laura Idda, Rachel Munk, Kotb Abdelmohsen, et al.
Wiley Interdisciplinary Reviews - RNA (2018) Vol. 9, Iss. 2
Open Access | Times Cited: 196
Challenges and hopes for Alzheimer’s disease
Suren A. Tatulian
Drug Discovery Today (2022) Vol. 27, Iss. 4, pp. 1027-1043
Closed Access | Times Cited: 195
Suren A. Tatulian
Drug Discovery Today (2022) Vol. 27, Iss. 4, pp. 1027-1043
Closed Access | Times Cited: 195
APOE2: protective mechanism and therapeutic implications for Alzheimer’s disease
Zonghua Li, Francis Shue, Na Zhao, et al.
Molecular Neurodegeneration (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 169
Zonghua Li, Francis Shue, Na Zhao, et al.
Molecular Neurodegeneration (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 169
A logical network-based drug-screening platform for Alzheimer’s disease representing pathological features of human brain organoids
Jong‐Chan Park, So‐Yeong Jang, Dongjoon Lee, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 152
Jong‐Chan Park, So‐Yeong Jang, Dongjoon Lee, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 152
Apolipoprotein E Promotes Immune Suppression in Pancreatic Cancer through NF-κB–Mediated Production of CXCL1
Samantha B. Kemp, Eileen S. Carpenter, Nina G. Steele, et al.
Cancer Research (2021) Vol. 81, Iss. 16, pp. 4305-4318
Open Access | Times Cited: 125
Samantha B. Kemp, Eileen S. Carpenter, Nina G. Steele, et al.
Cancer Research (2021) Vol. 81, Iss. 16, pp. 4305-4318
Open Access | Times Cited: 125
Neuronal ROS-induced glial lipid droplet formation is altered by loss of Alzheimer’s disease–associated genes
Matthew J. Moulton, Scott Barish, Isha Ralhan, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 52
Open Access | Times Cited: 116
Matthew J. Moulton, Scott Barish, Isha Ralhan, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 52
Open Access | Times Cited: 116
Resilience to autosomal dominant Alzheimer’s disease in a Reelin-COLBOS heterozygous man
Francisco Lopera, Claudia Mariño, Anita Chandrahas, et al.
Nature Medicine (2023) Vol. 29, Iss. 5, pp. 1243-1252
Open Access | Times Cited: 105
Francisco Lopera, Claudia Mariño, Anita Chandrahas, et al.
Nature Medicine (2023) Vol. 29, Iss. 5, pp. 1243-1252
Open Access | Times Cited: 105
APOE4 derived from astrocytes leads to blood–brain barrier impairment
Rosemary J. Jackson, Jonah C Meltzer, Huong Nguyen, et al.
Brain (2021) Vol. 145, Iss. 10, pp. 3582-3593
Open Access | Times Cited: 103
Rosemary J. Jackson, Jonah C Meltzer, Huong Nguyen, et al.
Brain (2021) Vol. 145, Iss. 10, pp. 3582-3593
Open Access | Times Cited: 103
Apolipoprotein E in lipid metabolism and neurodegenerative disease
Linda Yang, Zachary M. March, Roxan A. Stephenson, et al.
Trends in Endocrinology and Metabolism (2023) Vol. 34, Iss. 8, pp. 430-445
Open Access | Times Cited: 73
Linda Yang, Zachary M. March, Roxan A. Stephenson, et al.
Trends in Endocrinology and Metabolism (2023) Vol. 34, Iss. 8, pp. 430-445
Open Access | Times Cited: 73
Machine Learning and Digital Biomarkers Can Detect Early Stages of Neurodegenerative Diseases
Artur Chudzik, Albert Śledzianowski, Andrzej W. Przybyszewski
Sensors (2024) Vol. 24, Iss. 5, pp. 1572-1572
Open Access | Times Cited: 27
Artur Chudzik, Albert Śledzianowski, Andrzej W. Przybyszewski
Sensors (2024) Vol. 24, Iss. 5, pp. 1572-1572
Open Access | Times Cited: 27
Role of the peripheral innate immune system in the development of Alzheimer's disease
Aurélie Le Page, Gilles Dupuis, Éric Frost, et al.
Experimental Gerontology (2017) Vol. 107, pp. 59-66
Closed Access | Times Cited: 139
Aurélie Le Page, Gilles Dupuis, Éric Frost, et al.
Experimental Gerontology (2017) Vol. 107, pp. 59-66
Closed Access | Times Cited: 139
Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer’s disease: An integrative review
Mark J. Millan
Progress in Neurobiology (2017) Vol. 156, pp. 1-68
Closed Access | Times Cited: 137
Mark J. Millan
Progress in Neurobiology (2017) Vol. 156, pp. 1-68
Closed Access | Times Cited: 137
The Epigenetics of Alzheimer’s Disease: Factors and Therapeutic Implications
Xiaolei Liu, Bin Jiao, Lu Shen
Frontiers in Genetics (2018) Vol. 9
Open Access | Times Cited: 133
Xiaolei Liu, Bin Jiao, Lu Shen
Frontiers in Genetics (2018) Vol. 9
Open Access | Times Cited: 133
Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk
Yu‐Wen Alvin Huang, Bo Zhou, Amber M. Nabet, et al.
Journal of Neuroscience (2019) Vol. 39, Iss. 37, pp. 7408-7427
Open Access | Times Cited: 121
Yu‐Wen Alvin Huang, Bo Zhou, Amber M. Nabet, et al.
Journal of Neuroscience (2019) Vol. 39, Iss. 37, pp. 7408-7427
Open Access | Times Cited: 121
Invited Review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer's disease
Makis Tzioras, C. T. M. Davies, Andrew J. Newman, et al.
Neuropathology and Applied Neurobiology (2018) Vol. 45, Iss. 4, pp. 327-346
Open Access | Times Cited: 118
Makis Tzioras, C. T. M. Davies, Andrew J. Newman, et al.
Neuropathology and Applied Neurobiology (2018) Vol. 45, Iss. 4, pp. 327-346
Open Access | Times Cited: 118
Neuronal apolipoprotein E4 increases cell death and phosphorylated tau release in alzheimer disease
Anil R. Wadhwani, Amira Affaneh, Stephanie Van Gulden, et al.
Annals of Neurology (2019) Vol. 85, Iss. 5, pp. 726-739
Open Access | Times Cited: 116
Anil R. Wadhwani, Amira Affaneh, Stephanie Van Gulden, et al.
Annals of Neurology (2019) Vol. 85, Iss. 5, pp. 726-739
Open Access | Times Cited: 116
Clearance of beta-amyloid is facilitated by apolipoprotein E and circulating high-density lipoproteins in bioengineered human vessels
Jérôme Robert, Emily B. Button, Brian Yuen, et al.
eLife (2017) Vol. 6
Open Access | Times Cited: 104
Jérôme Robert, Emily B. Button, Brian Yuen, et al.
eLife (2017) Vol. 6
Open Access | Times Cited: 104
Beyond the CNS: The many peripheral roles of APOE
Ana Martínez, Elena Torres-Pérez, Nicholas A. Devanney, et al.
Neurobiology of Disease (2020) Vol. 138, pp. 104809-104809
Open Access | Times Cited: 94
Ana Martínez, Elena Torres-Pérez, Nicholas A. Devanney, et al.
Neurobiology of Disease (2020) Vol. 138, pp. 104809-104809
Open Access | Times Cited: 94
New therapeutics beyond amyloid-β and tau for the treatment of Alzheimer’s disease
Feng Zhang, Rujia Zhong, Cheng Cheng, et al.
Acta Pharmacologica Sinica (2020) Vol. 42, Iss. 9, pp. 1382-1389
Open Access | Times Cited: 72
Feng Zhang, Rujia Zhong, Cheng Cheng, et al.
Acta Pharmacologica Sinica (2020) Vol. 42, Iss. 9, pp. 1382-1389
Open Access | Times Cited: 72
The Potential Role of Ferroptosis in Alzheimer’s Disease
Guimei Zhang, Ya-Ru Zhang, Yanxin Shen, et al.
Journal of Alzheimer s Disease (2021) Vol. 80, Iss. 3, pp. 907-925
Closed Access | Times Cited: 57
Guimei Zhang, Ya-Ru Zhang, Yanxin Shen, et al.
Journal of Alzheimer s Disease (2021) Vol. 80, Iss. 3, pp. 907-925
Closed Access | Times Cited: 57